| abstract |
(a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, a crystalline form of the compound, a process for obtaining the compound, a pharmaceutical intermediate used in the preparation of the compound, and the compound Pharmaceutical compositions are provided. The compounds are useful for the treatment of diseases / conditions in which modulation of chemokine receptor activity is beneficial. (I) |